Funding and Licensing Opportunities and Challenges for Biopharma in APAC, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speaker will discuss how to mitigate the challenges faced by APAC biotechs seeking to gain access to US/EU investors and partners. Attendees will understand how to maximize potential interest from outside investors in APAC markets and how to strengthen the case for valuation and market potential of assets.

These markets offer various unique advantages for investors: some have strong areas of expertise that are ripe for investment, such as animal health in Australia, while others offer unique opportunities like the accelerated regulatory environment in China.

The biopharmaceutical industry is rapidly expanding all over the world. Traditional markets such as the United States and Europe continue to lead much of the industry, but it is becoming impossible to ignore the explosive growth in the Asia and Pacific (APAC) region, driven largely by countries like China, India and Japan. While venture capital investment may have slowed overall in the face of the pandemic, this was not so in APAC. In Chinese biotech alone, for example, the first half of 2020 saw 95 biotech deals, worth $12 billion: an unprecedented amount of activity.

These markets offer various unique advantages for investors: some have strong areas of expertise that are ripe for investment, such as animal health in Australia, while others offer unique opportunities like the accelerated regulatory environment in China. APAC has increasingly drawn interest from investors and multinationals, and is seen to be a significant source of innovation. There is no question that all eyes are on APAC as a potential opportunity for placing bets.

Join Neel Patel, Executive Managing Director and Head, Commercial Advisory Group, Syneos Health in a live webinar on Thursday, March 11, 2021 at 11am JST (Japan) to hear a discussion on the opportunities and challenges of funding and licensing for biopharma in APAC, and how biotech companies can take advantage of the favorable market conditions in this region to bring their innovations through development and to market – in APAC and around the world.

For more information, or to register for this event, visit Funding and Licensing Opportunities and Challenges for Biopharma in APAC.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website